Diabetes

Diabetes results in $218 billion in medical costs and lost productivity annually.

10

Sites with Diabetes Expertise

90+

Diabetes Clinical Trials

~14,000

Patients with Diabetes

ERG's commitment to diabetes research is driven by scientific leadership, therapeutic expertise, and a culture of continuous innovation. By combining experienced investigators, specialized metabolic research sites, and advanced participant recruitment strategies, ERG delivers the capabilities needed to support high-quality diabetes clinical trials across all phases of development.

Experience Across Key Diabetic Indications

Diabetes Mellitus, Diabetic retinopathy, Diabetes with neurological manifestations, Diabetes with other specified manifestations, Diabetes with peripheral circulatory disorders, Diabetes with unspecified complications.

Industry-Leading Diabetes Expertise

Successful diabetes clinical trials require expertise that extends beyond endocrinology alone. ERG combines specialists across multiple therapeutic disciplines, including neurology, pain management, physical medicine, and psychiatry, to provide a comprehensive scientific perspective that enhances protocol development, participant management, and trial execution throughout the clinical development lifecycle.

Comprehensive Diabetes Clinical Trial Capabilities

Diabetes is a complex metabolic disease requiring specialized expertise in both glycemic regulation and the management of multisystem complications. Leveraging specialized capabilities including glucose clamp methodologies, continuous glucose monitoring, tolerance testing, stable isotope techniques, metabolic imaging, and cardiometabolic assessments under the scientific leadership of Chief Scientific Officer Clayton Dehn, a distinguished industry expert in metabolic pharmacodynamics, glucose metabolism, and biomarker- driven clinical research, ERG is uniquely positioned to support scientifically rigorous clinical research designed to generate high-quality clinical evidence across the full spectrum of diabetes drug development.

Rapid, Targeted Diabetic Patient Recruitment and Database Strength

ERG's comprehensive prescreening process incorporates diabetes diagnosis, medication history, HbA1c, and liver and kidney function to identify appropriately characterized participants. Combined with centralized and local recruitment strategies and proprietary technology-enabled recruitment tools, ERG rapidly identifies participants who meet protocol-specific eligibility criteria, helping sponsors accelerate enrollment in diabetes clinical trials.

Get in Touch

ERG’s mission is to provide the highest quality clinical trial execution across all clinical research phases to help sponsors.